Notification report

Full notification file

General information

Notification Number

Member State to which the notification was sent

Date of acknowledgement from the Member State Competent Authority

Title of the Project
Assessment of the safety and immunogenicity of administering MVA, carrying HIV-1 genes
env, gag, and pol in subjects who have previously received plasmid DNA with analogous HIV-
1 genes in HIVIS 01.

Proposed period of release:
01/08/2005 to 31/03/2006

Name of the Institute(s) or Company(ies)
Swedish institute for Infectious Disease
Control, Stockholm, Sweden;

3. Is the same GMO release planned elsewhere in the Community?

Has the same GMO been notified elsewhere by the same notifier?

GMO characterization

GMO is a:
DNA Virus

Identity of the GMO:
Modified Vaccinia Ankara Chang Mai Double Recombinant (MVA-CMDR)

Information relating to the recipient or parental organisms from wich the GMO is derived
Common NameGenusSpeciesSubspeciesStrainPathovar
MVAorthopoxvirusvaccinia virusModified Virus Ankara

European Commission administrative information

Consent given by the Member State Competent Authority:
Not known